Synergistic Endoprosthesis System for Enhanced Vasculature Treatment

The present inventive concept integrates balloon expandable endoprostheses with distinct technologies such as AI, IoT, blockchain, and novel materials to create a more powerful system for treating vasculature, enabling real-time monitoring, optimization, and personalized treatment strategies.

The original patent disclosed balloon expandable endoprostheses for treating vasculature, but it lacked the ability to provide real-time monitoring and optimization, secure data management, and personalized treatment strategies. The present inventive concept addresses these limitations by combining the endoprosthesis with advanced technologies to create a more effective and efficient system.

The synergistic endoprosthesis system comprises a balloon expandable endoprosthesis integrated with a machine learning algorithm for real-time monitoring and optimization of the endoprosthesis deployment. The algorithm utilizes data from sensors embedded within the endoprosthesis to predict optimal deployment configurations. Additionally, the system includes a blockchain-based data management system to securely store and track patient-specific data and treatment outcomes. The system also features a network of IoT-enabled sensors disposed within the endoprosthesis and a cloud-based data analytics platform, which analyzes data from the sensors to predict potential complications and provide personalized recommendations for treatment. Furthermore, the endoprosthesis is made of a novel material with enhanced biocompatibility and durability, and is integrated with an AI-powered decision support system for guiding clinicians in selecting optimal treatment strategies.

The new claims introduce the integration of distinct technologies such as AI, IoT, blockchain, and novel materials with the balloon expandable endoprosthesis, which is not obvious from the original patent. The synergistic combination of these technologies provides a new and non-obvious solution for treating vasculature.

Alternative embodiments of the inventive concept could include integrating the endoprosthesis with other advanced technologies such as robotics, virtual reality, or 3D printing. Additionally, the system could be adapted for use in other medical applications beyond vasculature treatment.

The synergistic endoprosthesis system has significant commercial potential in the medical device industry, particularly in the areas of cardiovascular and peripheral vascular disease treatment. The system's ability to provide real-time monitoring, optimization, and personalized treatment strategies could revolutionize the treatment of vasculature diseases, offering a significant market opportunity.